LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson’s Disease Mouse Model

Hien Tran Zhao, Neena John, Vedad Delic, Karli Ikeda-Lee, Aneeza Kim, Andreas Weihofen, Eric E. Swayze, Holly B. Kordasiewicz, Andrew B. West, Laura A. Volpicelli‐Daley
ISSN / E-ISSN
— / —
DOI
10.1016/j.omtn.2017.08.002 ↗
Volume · Issue · Pages
8 · — · 508-519
Publisher
Cell Press
Article URL
https://doi.org/10.1016/j.omtn.2017.08.002 ↗
Article details
Unverified
Publication date (each date has its type and source)
10 Aug 2017
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date10 Aug 2017 OpenAlex

Keywords (as given): Parkinson's disease; LRRK2; antisense oligonucleotides; alpha-synuclein; alpha-synuclein inclusions; LRRK2 kinase inhibition; tyrosine hydroxylase; intracerebral injection; alpha-synuclein fibrils; neuroprotection

HEC Status at Publication Not the journal's current status

HEC Status at PublicationNot conclusive
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Journal
Molecular Therapy - Nucleic Acids
Publication date used
10 Aug 2017 (OpenAlex publication date)
Applicable HEC period
None recorded for this date
Category
—
Recognition status
Unknown (NO_PERIOD_FOR_DATE)
Source
—
Verification status
Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.